137 related articles for article (PubMed ID: 30143678)
1. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
Wang LH; Xu M; Fu LQ; Chen XY; Yang F
Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
[TBL] [Abstract][Full Text] [Related]
2. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
[TBL] [Abstract][Full Text] [Related]
3. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.
Su H; Jin X; Zhang X; Zhao L; Lin B; Li L; Fei Z; Shen L; Fang Y; Pan H; Xie C
J Transl Med; 2015 Mar; 13():104. PubMed ID: 25888911
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.
Kang HW; Kim JH; Lee DE; Lee YS; Kim MJ; Kim HS; Fang S; Lee BE; Lee KJ; Yoo J; Kim HJ; Park JS
Cancer Biol Ther; 2023 Dec; 24(1):2272334. PubMed ID: 37917550
[TBL] [Abstract][Full Text] [Related]
5. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification.
Huang J; Li H; Yang Z; Liu R; Li Y; Hu Y; Zhao S; Gao X; Yang X; Wei J
Cell Death Dis; 2024 Feb; 15(2):139. PubMed ID: 38355684
[TBL] [Abstract][Full Text] [Related]
6. LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway.
Ai Y; Wu S; Zou C; Wei H
J Cell Mol Med; 2020 Sep; 24(18):10512-10524. PubMed ID: 32691935
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Zhou SF; Qiu JX
Drug Des Devel Ther; 2015; 9():5511-51. PubMed ID: 26491260
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.
Aminuddin A; Ng PY; Leong CO; Chua EW
Sci Rep; 2020 May; 10(1):7885. PubMed ID: 32398775
[TBL] [Abstract][Full Text] [Related]
10. BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Yamamoto T; Hirosue A; Nakamoto M; Yoshida R; Sakata J; Matsuoka Y; Kawahara K; Nagao Y; Nagata M; Takahashi N; Hiraki A; Shinohara M; Nakao M; Saitoh N; Nakayama H
Br J Cancer; 2020 Aug; 123(4):580-590. PubMed ID: 32499570
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of β-catenin: Evidence of inhibition of Wnt/β-catenin signaling as an important antitumor mechanism of microtubule-targeting agents.
Kumari A; Shriwas O; Sisodiya S; Santra MK; Guchhait SK; Dash R; Panda D
FASEB J; 2021 Apr; 35(4):e21539. PubMed ID: 33742719
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma.
Giuliano A; Swift R; Arthurs C; Marote G; Abramo F; McKay J; Thomson C; Beltran M; Millar M; Priestnall S; Dobson J; Costantino-Casas F; Petrou T; McGonnell IM; Davies AJ; Weetman M; Garden OA; Masters JR; Thrasivoulou C; Ahmed A
PLoS One; 2016; 11(8):e0161103. PubMed ID: 27559731
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis.
Mook RA; Ren XR; Wang J; Piao H; Barak LS; Kim Lyerly H; Chen W
Bioorg Med Chem; 2017 Mar; 25(6):1804-1816. PubMed ID: 28233680
[TBL] [Abstract][Full Text] [Related]
14. Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.
Arend RC; Londoño-Joshi AI; Gangrade A; Katre AA; Kurpad C; Li Y; Samant RS; Li PK; Landen CN; Yang ES; Hidalgo B; Alvarez RD; Straughn JM; Forero A; Buchsbaum DJ
Oncotarget; 2016 Dec; 7(52):86803-86815. PubMed ID: 27888804
[TBL] [Abstract][Full Text] [Related]
15. F. Nucleatum enhances oral squamous cell carcinoma proliferation via E-cadherin/β-Catenin pathway.
Li Z; Liu Y; Huang X; Wang Q; Fu R; Wen X; Liu J; Zhang L
BMC Oral Health; 2024 May; 24(1):518. PubMed ID: 38698370
[TBL] [Abstract][Full Text] [Related]
16. The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model.
Ye T; Xiong Y; Yan Y; Xia Y; Song X; Liu L; Li D; Wang N; Zhang L; Zhu Y; Zeng J; Wei Y; Yu L
PLoS One; 2014; 9(1):e85887. PubMed ID: 24416452
[TBL] [Abstract][Full Text] [Related]
17. Small molecule modulators of Wnt/β-catenin signaling.
Mook RA; Chen M; Lu J; Barak LS; Lyerly HK; Chen W
Bioorg Med Chem Lett; 2013 Apr; 23(7):2187-91. PubMed ID: 23453073
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure.
Mook RA; Wang J; Ren XR; Chen M; Spasojevic I; Barak LS; Lyerly HK; Chen W
Bioorg Med Chem; 2015 Sep; 23(17):5829-38. PubMed ID: 26272032
[TBL] [Abstract][Full Text] [Related]
19. DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells.
Nikitakis NG; Gkouveris I; Aseervatham J; Barahona K; Ogbureke KUE
Cell Mol Biol Lett; 2018; 23():30. PubMed ID: 30002682
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.
Mallery SR; Wang D; Santiago B; Pei P; Bissonnette C; Jayawardena JA; Schwendeman SP; Spinney R; Lang J
Mol Cancer Ther; 2019 Dec; 18(12):2308-2320. PubMed ID: 31515297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
